Application of composition in preparation of sweeteners and blood sugar reducing products for diabetic patients
A technology of composition and sweetener, which is applied in application, food preparation, drug combination, etc., can solve the problems of difficulty in meeting the basic dietary requirements of diabetic patients, no hypoglycemic effect, and bad flavor, so as to achieve mild effect, Fast-acting, low-cost results
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] Embodiment 1, the combination mode of the composition of the present invention
[0030]Weigh the corresponding raw materials according to the weight ratios of seaweed substances and enzyme inhibitors in Table 1, and mix them directly to form a powder composition, or dissolve them in water to make a composition solution after mixing. The validamycin of the embodiment can be one or more mixtures of validamycin A-H (there is no difference in the inhibitory effect of enzymes using different isomers), mainly validamycin A; trehalose is trehalose (α , α), a mixture of isotrehalose (β, β) and neotrehalose (α, β).
[0031] The combination mode of table 1 composition of the present invention
[0032]
[0033] Further, the solid composition or composition solution can be used to make preparations by conventional methods, not listed one by one.
experiment example
[0034] Experimental example: the absorption situation of the composition of the present invention in the body
[0035] 1. Experimental animals and materials
[0036] Male ICR mice, 8 weeks old, weighing 20±2g, were purchased from Beijing Huafukang Experimental Animal Company;
[0037] The composition of this experimental example:
[0038] Composition 1 solution: Take 15g of trehalose and 3mg of validamycin, and prepare a composition 1 solution with 100mL of medical sterile water for use.
[0039] 2. Experimental method
[0040] After feeding the mice normally for 3 days, they were fasted for 12 hours without water, and randomly divided into 4 groups according to the blood sugar level, blank control group, drug treatment group, and negative control group 1-2. The administration group was given this experimental example composition 1 solution by intragastric administration according to the amount of 13.3mL / kg according to the body weight of the mice; 2 Inject 0.15 g / mL treha...
Embodiment 2
[0044] Example 2, the hypoglycemic effect of the composition on diabetic mice
[0045] 1. Experimental animals and materials
[0046] Male ICR mice, 8 weeks old, weighing 20±2g, were purchased from Beijing Huafukang Experimental Animal Company;
[0047] The present embodiment composition solution:
[0048] Composition 1 solution: Take 15g of trehalose and 3mg of validamycin, and prepare a composition 1 solution with 100mL of medical sterile water for use;
[0049] Composition 2 solution: take 300g of trehalose and 3mg of validamycin, and prepare a composition 2 solution with 100mL of medical sterile water for use;
[0050] Composition 3 solution: take 600g of trehalose and 3mg of validamycin, and prepare a composition 3 solution with 100mL medical sterile water, and set aside;
[0051] Composition 4 solution: take 15g of trehalose and 3mg of hexaconazole, and prepare a composition 4 solution with 100mL of medical sterile water for use;
[0052] Composition 5 solution: take...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com